Therapeutic Effect of the Antiviral Agent Ribavirin in Junin Virus Infection of Primates

✍ Scribed by Dr. Mercedes C. Weissenbacher; Miguel A. Calello; Maria S. Merani; Marcos Rodriguez; Joseph B. McCormick

• Publisher: John Wiley and Sons
• Year: 1986
• Tongue: English
• Weight: 375 KB
• Volume: 20
• Category: Article
• ISSN: 0146-6615
• DOI: 10.1002/jmv.1890200308

✦ Synopsis

In order to assess the effect of the antiviral Ribavirin on the course of Junín virus infection in Callithrix jacchus, seven inoculated monkeys were treated with 15 mg of the drug, twice a day, starting 6 days after infection when all animals were viremic. The three untreated controls showed typical signs of Junín virus infection at 14 days pi and their mean time of death was 18 days. In contrast, no signs of illness were detected in Ribavirin-treated animals until 24 days pi, when marmosets showed signs of neurological involvement: 5 of these animals died (mean day of death: 36) but the two remaining treated monkeys improved and survived infection without sequelae. The comparison of survival rates (0% vs 28%) and the delay of the mean day of death observed indicates that the Ribavirin treatment used has therapeutic effect on Junín virus infection in vivo.